These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 15844786)
1. Medullary thyroid carcinoma in a child with a new RET mutation and a RET polymorphism. Vandenbosch K; Renard M; Uyttebroeck A; Sciot R; Matthijs G; Legius E Genet Couns; 2005; 16(1):95-100. PubMed ID: 15844786 [TBL] [Abstract][Full Text] [Related]
2. A novel germ-line point mutation in RET exon 8 (Gly(533)Cys) in a large kindred with familial medullary thyroid carcinoma. Da Silva AM; Maciel RM; Da Silva MR; Toledo SR; De Carvalho MB; Cerutti JM J Clin Endocrinol Metab; 2003 Nov; 88(11):5438-43. PubMed ID: 14602786 [TBL] [Abstract][Full Text] [Related]
3. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation. Jaggard MK; MacRae C; Ifeacho S; Robinson S; Tolley NS J Laryngol Otol; 2009 Jul; 123(7):796-800. PubMed ID: 18771606 [TBL] [Abstract][Full Text] [Related]
4. Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition. Elisei R; Cosci B; Romei C; Agate L; Piampiani P; Miccoli P; Berti P; Basolo F; Ugolini C; Ciampi R; Nikiforov Y; Pinchera A J Clin Endocrinol Metab; 2004 Nov; 89(11):5823-7. PubMed ID: 15531548 [TBL] [Abstract][Full Text] [Related]
6. RET polymorphisms in codons 769 and 836 are not associated with predisposition to medullary thyroid carcinoma. Wiench M; Włoch J; Wygoda Z; Gubała E; Oczko M; Pawlaczek A; Kula D; Lange D; Jarzab B Cancer Detect Prev; 2004; 28(4):231-6. PubMed ID: 15350625 [TBL] [Abstract][Full Text] [Related]
7. Screening of six risk exons of the RET proto-oncogene in families with medullary thyroid carcinoma in the Czech Republic. Jindrichová S; Vcelák J; Vlcek P; Neradilová M; Nemec J; Bendlová B J Endocrinol; 2004 Nov; 183(2):257-65. PubMed ID: 15531714 [TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the RET proto-oncogene and the phenotypic presentation of familial medullary thyroid carcinoma. Magalhães PK; de Castro M; Elias LL; Soares EG; Maciel LM Thyroid; 2004 Oct; 14(10):848-52. PubMed ID: 15588382 [TBL] [Abstract][Full Text] [Related]
10. RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population. Elisei R; Cosci B; Romei C; Bottici V; Sculli M; Lari R; Barale R; Pacini F; Pinchera A J Clin Endocrinol Metab; 2004 Jul; 89(7):3579-84. PubMed ID: 15240649 [TBL] [Abstract][Full Text] [Related]
11. Functional characterization of the MTC-associated germline RET-K666E mutation: evidence of oncogenic potential enhanced by the G691S polymorphism. Borrello MG; Aiello A; Peissel B; Rizzetti MG; Mondellini P; Degl'Innocenti D; Catalano V; Gobbo M; Collini P; Bongarzone I; Pierotti MA; Greco A; Seregni E Endocr Relat Cancer; 2011 Aug; 18(4):519-27. PubMed ID: 21690267 [TBL] [Abstract][Full Text] [Related]
12. Medullary and papillary carcinoma of the thyroid gland occurring as a collision tumour: report of three cases with molecular analysis and review of the literature. Rossi S; Fugazzola L; De Pasquale L; Braidotti P; Cirello V; Beck-Peccoz P; Bosari S; Bastagli A Endocr Relat Cancer; 2005 Jun; 12(2):281-9. PubMed ID: 15947103 [TBL] [Abstract][Full Text] [Related]
13. A rare RET gene exon 8 mutation is found in two Greek kindreds with familial medullary thyroid carcinoma: implications for screening. Kaldrymides P; Mytakidis N; Anagnostopoulos T; Vassiliou M; Tertipi A; Zahariou M; Rampias T; Koutsodontis G; Konstantopoulou I; Ladopoulou A; Bei T; Yannoukakos D Clin Endocrinol (Oxf); 2006 May; 64(5):561-6. PubMed ID: 16649977 [TBL] [Abstract][Full Text] [Related]
14. [Association of deletions of the RET proto-oncogene wtih aggressive course of sporatic C-cell carcinoma]. Musholt PB; Musholt TJ; Moley JF; Scheumann GF Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):261-5. PubMed ID: 14518256 [TBL] [Abstract][Full Text] [Related]
15. [Analysis of mutations in the RET proto-oncogene in patients with medullary thyroid tumor]. Amosenko FA; Brzhezovskiĭ VZh; Liubchenko LN; Shabanov MA; Kozlova VM; Vanushko VE; Kazubskaia TP; Gar'kavtseva RF; Kalinin VN Genetika; 2003 Jun; 39(6):847-54. PubMed ID: 12884527 [TBL] [Abstract][Full Text] [Related]
16. Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre. Bugalho MJ; Domingues R; Santos JR; Catarino AL; Sobrinho L Surgery; 2007 Jan; 141(1):90-5. PubMed ID: 17188172 [TBL] [Abstract][Full Text] [Related]
17. Analysis of inherited genetic variants in ret proto-oncogene of Brazilian patients with apparently sporadic medullary thyroid carcinoma. Guerrero IM; Pessoa CH; Olmedo DB; Pontes ER; Matos LC; Tilli TM; Barcinski MA; Gimba ER Thyroid; 2006 Jan; 16(1):9-15. PubMed ID: 16487008 [TBL] [Abstract][Full Text] [Related]
18. [Mutations of ret-proto-oncogene in thyroid medullary carcinoma]. Frank-Raue K; Höppner W; Buhr H; Herfarth C; Ziegler R; Raue F Dtsch Med Wochenschr; 1997 Feb; 122(6):143-9. PubMed ID: 9081799 [TBL] [Abstract][Full Text] [Related]
19. The Ret proto-oncogene in the WAG/Rij rat strain: an animal model for inherited C-cell carcinoma? De Miguel M; Fernández-Santos JM; Trigo-Sánchez I; Matera I; Ceccherini I; Martín I; Romeo G; Galera-Davidson H Lab Anim; 2003 Jul; 37(3):215-21. PubMed ID: 12869284 [TBL] [Abstract][Full Text] [Related]
20. Concurrent lymph node metastases of medullary and papillary thyroid carcinoma in a case with RET oncogene germline mutation. Papi G; Corrado S; Pomponi MG; Carapezzi C; Cesinaro A; LiVolsi VA Endocr Pathol; 2003; 14(3):269-76. PubMed ID: 14586073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]